Artículos de revistas sobre el tema "XP"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "XP".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Cowham, R. "To XP or not to XP?" ITNOW 47, n.º 2 (1 de marzo de 2005): 16. http://dx.doi.org/10.1093/itnow/bwi030.
Texto completoFischer, R., M. Uhl y H. Vonach. "Nb93(n,xp),Agnat(n,xp), andInnat(n,xp) reactions at 14.1 MeV". Physical Review C 37, n.º 2 (1 de febrero de 1988): 578–86. http://dx.doi.org/10.1103/physrevc.37.578.
Texto completoLitts, Thom y Jeff Kopaska. "RIP XP". Fisheries 39, n.º 4 (3 de abril de 2014): 151. http://dx.doi.org/10.1080/03632415.2014.893871.
Texto completoSonia, Archana Singhal y Hema Banati. "FISA-XP". ACM SIGSOFT Software Engineering Notes 39, n.º 3 (4 de junio de 2014): 1–14. http://dx.doi.org/10.1145/2597716.2597728.
Texto completoLee, Jeeyun, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim et al. "Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial". Journal of Clinical Oncology 30, n.º 3 (20 de enero de 2012): 268–73. http://dx.doi.org/10.1200/jco.2011.39.1953.
Texto completoIvorra, Wilfrid. "Sur les équations xp+2βyp= z2et xp+2βyp= 2z2". Acta Arithmetica 108, n.º 4 (2003): 327–38. http://dx.doi.org/10.4064/aa108-4-3.
Texto completoFassihi, Hiva, Mieran Sethi, Heather Fawcett, Jonathan Wing, Natalie Chandler, Shehla Mohammed, Emma Craythorne et al. "Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect". Proceedings of the National Academy of Sciences 113, n.º 9 (16 de febrero de 2016): E1236—E1245. http://dx.doi.org/10.1073/pnas.1519444113.
Texto completoKunwar, Sundar. "Enabling and Limiting factors in eXtreme Programming (XP) with Evaluation Framework". SCITECH Nepal 14, n.º 1 (9 de septiembre de 2019): 50–62. http://dx.doi.org/10.3126/scitech.v14i1.25534.
Texto completoMaxmen, Amy. "XP mutant power!" Journal of Experimental Medicine 206, n.º 13 (30 de noviembre de 2009): 2856. http://dx.doi.org/10.1084/jem.20613iti2.
Texto completoRapićOtrin, Vesna, Isao Kuraoka, Tiziana Nardo, Mary McLenigan, A. P. M. Eker, Miria Stefanini, Arthur S. Levine y Richard D. Wood. "Relationship of the Xeroderma Pigmentosum Group E DNA Repair Defect to the Chromatin and DNA Binding Proteins UV-DDB and Replication Protein A". Molecular and Cellular Biology 18, n.º 6 (1 de junio de 1998): 3182–90. http://dx.doi.org/10.1128/mcb.18.6.3182.
Texto completoStanojevic, Jelena. "On estimation of high quantiles for certain classes of distributions". Yugoslav Journal of Operations Research 25, n.º 2 (2015): 299–312. http://dx.doi.org/10.2298/yjor130606013s.
Texto completoSuman, AHM Khairul Imam, Khadija Begum, Kaniz Rahman, Abu Mohammed Talukder, SM Matiur Rahman, Md Akmat Ali, Nusrath Jahan Hoque y Mohammad Morshad Alam. "Association of Xanthelasma palpebrarum (XP) with cardiovascular disease (CVD) risk factors". Asian Journal of Medical and Biological Research 5, n.º 4 (3 de febrero de 2020): 324–29. http://dx.doi.org/10.3329/ajmbr.v5i4.45271.
Texto completoVaz-Garcia, Eduarda Santiago, Victor Talarico Leal Vieira, Natasha Pereira da Silva Ferreira Petitet, Edson Jorge Lima Moreira, Hélio Pereira Lopes, Carlos Nelson Elias, Emmanuel João Nogueira Leal Silva y Henrique dos Santos Antunes. "Mechanical Properties of Anatomic Finishing Files: XP-Endo Finisher and XP-Clean". Brazilian Dental Journal 29, n.º 2 (marzo de 2018): 208–13. http://dx.doi.org/10.1590/0103-6440201801903.
Texto completoPrice, Vera H. "Trichothiodystrophy: Current Concepts". Journal of Cutaneous Medicine and Surgery 1, n.º 1 (julio de 1996): 45–49. http://dx.doi.org/10.1177/120347549600100113.
Texto completoMiao, Junjie, Changchun Chai, Wei Zhang, Yanxing Song y Yintang Yang. "First-Principles Study on Structural, Mechanical, Anisotropic, Electronic and Thermal Properties of III-Phosphides: XP (X = Al, Ga, or In) in the P6422 Phase". Materials 13, n.º 3 (4 de febrero de 2020): 686. http://dx.doi.org/10.3390/ma13030686.
Texto completoLee, J., W. Kang, D. Lim, J. Park, Y. Park, H. Lim, T. Sohn, J. Noh, J. Bae y S. Kim. "Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 4537. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4537.
Texto completoFernández-Sánchez, Javier. "Against a clausal ellipsis account of all stripping strings in Spanish". Poznan Studies in Contemporary Linguistics 55, n.º 1 (26 de marzo de 2018): 53–87. http://dx.doi.org/10.1515/psicl-2019-0003.
Texto completoRana, MS, MM Rahman, UK Rima y NS Juyena. "General anaesthesia of indigenous pigs in Bangladesh". Bangladesh Veterinarian 30, n.º 2 (6 de marzo de 2014): 46–53. http://dx.doi.org/10.3329/bvet.v30i2.18254.
Texto completoKarentz, D. y J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, n.º 10 (octubre de 1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428.
Texto completoKarentz, D. y J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells". Molecular and Cellular Biology 6, n.º 10 (octubre de 1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428-3432.1986.
Texto completoMartens, M. C., L. Boeckmann y S. Emmert. "Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom". Aktuelle Dermatologie 46, n.º 08/09 (20 de agosto de 2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Texto completoRothkopf, Michael. "An Algorithmic Approach for Lipid Metabolism and Management of Patients with Xanthelasma Palpebrarum (XP)". Current Developments in Nutrition 4, Supplement_2 (29 de mayo de 2020): 1140. http://dx.doi.org/10.1093/cdn/nzaa055_025.
Texto completoAlakshar, Asmaa, Abdul Rahman Mohammed Saleh y Mehmet Omer Gorduysus. "Debris and Smear Layer Removal from Oval Root Canals Comparing XP-Endo Finisher, EndoActivator, and Manual Irrigation: A SEM Evaluation". European Journal of Dentistry 14, n.º 04 (10 de agosto de 2020): 626–33. http://dx.doi.org/10.1055/s-0040-1714762.
Texto completoSugimoto, Naotoshi, Tetsuhiro Yoshinami, Sachiko Yamamoto, Toshinari Yagi y Fumio Imamura. "Does capecitabine plus cisplatin (XP) give advanced or recurrent gastric cancer (AGC) patients higher early tumor shrinkage (ETS) rate than S1 plus cisplatin (SP) with safety?" Journal of Clinical Oncology 33, n.º 3_suppl (20 de enero de 2015): 172. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.172.
Texto completoTakeno, Atsushi, Youichi Makari, Shunji Endo, Jin Matsuyama, Ryohei Kawabata, Naotoshi Sugimoto, Hirokazu Taniguchi et al. "Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial." Journal of Clinical Oncology 36, n.º 4_suppl (1 de febrero de 2018): 102. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.102.
Texto completoBahrudin, Ida Aryanie, Rafizah Mohd Hanifa, Mohd Ezree Abdullah y Muhammad Firdaus Kamarudin. "Adapting eXtreme Programming Approach in Developing Electronic Document Online System (eDoc)". Applied Mechanics and Materials 321-324 (junio de 2013): 2938–41. http://dx.doi.org/10.4028/www.scientific.net/amm.321-324.2938.
Texto completoGengler, Barbara. "XP a National Threat?" Network Security 2001, n.º 11 (noviembre de 2001): 5. http://dx.doi.org/10.1016/s1353-4858(01)01111-4.
Texto completoJ.-M.M. "XP Centaur en majesté". Revue Francophone des Laboratoires 2007, n.º 388 (enero de 2007): 10. http://dx.doi.org/10.1016/s1773-035x(07)80003-7.
Texto completoSchwarz, Diemo y Etienne Brunet. "theconcatenator: Placard XP edit". Leonardo Music Journal 18 (diciembre de 2008): 89–90. http://dx.doi.org/10.1162/lmj.2008.18.89b.
Texto completoReifer, D. J. "XP and the CMM". IEEE Software 20, n.º 3 (mayo de 2003): 14–15. http://dx.doi.org/10.1109/ms.2003.1196314.
Texto completoTorre, Alberto C. de la. "The ubiquitous XP commutator". European Journal of Physics 27, n.º 2 (3 de enero de 2006): 225–30. http://dx.doi.org/10.1088/0143-0807/27/2/005.
Texto completoFraser, Steven y Giancarlo Succi. "XP requirement negotiation workshop". ACM SIGAPP Applied Computing Review 10, n.º 1 (abril de 2002): 26–31. http://dx.doi.org/10.1145/568235.568239.
Texto completoYu, Jeong Il, Hee Chul Park, Jeeyun Lee, Changhoon Choi, Won Ki Kang, Se Hoon Park, Seung Tae Kim et al. "Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer". Cancers 12, n.º 4 (10 de abril de 2020): 943. http://dx.doi.org/10.3390/cancers12040943.
Texto completoPoulin, Yves, Robert Bissonnette, Christina Juneau, Kim Cantin, Rejean Drouin y Patrice E. Poubelle. "XP-828L in the Treatment of Mild to Moderate Psoriasis: Randomized, Double-Blind, Placebo-Controlled Study". Journal of Cutaneous Medicine and Surgery 10, n.º 5 (septiembre de 2006): 241–48. http://dx.doi.org/10.2310/7750.2006.00049.
Texto completoBeroual, Nabil y Ahmed Bendjeddou. "On a Predator–Prey System with Holling Functional Response: xp/(a + xp)". National Academy Science Letters 39, n.º 1 (12 de octubre de 2015): 43–46. http://dx.doi.org/10.1007/s40009-015-0400-6.
Texto completoYang, Tianyu, Can Ding, Richard W. Ziolkowski y Y. Jay Guo. "A Terahertz (THz) Single-Polarization-Single-Mode (SPSM) Photonic Crystal Fiber (PCF)". Materials 12, n.º 15 (31 de julio de 2019): 2442. http://dx.doi.org/10.3390/ma12152442.
Texto completoLee, Ji Eun, Myung Ah Lee, Tae Ho Hong, In Seok Lee y Young Kyoung You. "Comparison of the efficacy between the gemcitabine/cisplatin (GP) and capecitabine/cisplatin (XP) for the advanced biliary tract cancer: Retrospective analysis in a single institution." Journal of Clinical Oncology 30, n.º 4_suppl (1 de febrero de 2012): 365. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.365.
Texto completoDe Braud, Filippo G. y Wentao Jason Wu. "A dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of mTORC1/2 inhibitor XP-105 (BI 860585) as monotherapy and in combination with exemestane or paclitaxel in patients (pts) with advanced solid tumors." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 3127. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3127.
Texto completoBen Rekaya, Mariem, Nadia Laroussi, Olfa Messaoud, Mariem Jones, Manel Jerbi, Chokri Naouali, Yosra Bouyacoub et al. "A Founder Large Deletion Mutation in Xeroderma Pigmentosum-Variant Form in Tunisia: Implication for Molecular Diagnosis and Therapy". BioMed Research International 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/256245.
Texto completoKrasikova, Yuliya, Nadejda Rechkunova y Olga Lavrik. "Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities". International Journal of Molecular Sciences 22, n.º 12 (9 de junio de 2021): 6220. http://dx.doi.org/10.3390/ijms22126220.
Texto completoPoddar, Rakshapada, Subhradeep Chakraborty y Sudipta Chattopadhyay. "Improved Cross Polarization and Broad Impedance Bandwidth from Simple Single Element Shorted Rectangular Microstrip Patch: Theory and Experiment". Frequenz 70, n.º 1-2 (1 de enero de 2016): 1–9. http://dx.doi.org/10.1515/freq-2015-0105.
Texto completoGarcía-García, J. I., D. Marín-Aragón y A. Vigneron-Tenorio. "Union of Sets of Lengths of Numerical Semigroups". Mathematics 8, n.º 10 (15 de octubre de 2020): 1789. http://dx.doi.org/10.3390/math8101789.
Texto completoMulyantari, Kadek, Aryati . y M. Y. Probohoesodo. "PENEMUAN (DETEKSI) ANTIBODI UNTUK ANTIGEN TUBERKULOSIS MENGGUNAKAN METODE IMUNOKROMATOGRAFI DI PENDERITA TUBERKULOSIS PARU". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 14, n.º 3 (16 de marzo de 2018): 127. http://dx.doi.org/10.24293/ijcpml.v14i3.938.
Texto completoKang, Y., W. K. Kang, D. B. Shin, J. Chen, J. Xiong, J. Wang, M. Lichinitser, M. Philco, T. Suarez y J. Santamaria. "Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): LBA4018. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.lba4018.
Texto completoArmelini, Melissa G., Keronninn M. Lima-Bessa, Maria Carolina N. Marchetto, Alysson R. Muotri, Vanessa Chiganças, Ricardo A. Leite, Helotonio Carvalho y Carlos F. M. Menck. "Exploring DNA damage responses in human cells with recombinant adenoviral vectors". Human & Experimental Toxicology 26, n.º 11 (noviembre de 2007): 899–906. http://dx.doi.org/10.1177/0960327107083556.
Texto completoBeal Partyka, Raul, Jeferson Lana y Rosilene Marcon. "A XP e o Itaú Unibanco: dos Produtos de Investimento a Desbancarização". Administração: Ensino e Pesquisa 21, n.º 2 (1 de mayo de 2020): 214–38. http://dx.doi.org/10.13058/raep.2020.v21n2.1749.
Texto completoDrouin, Réjean, Éric Lamiot, Kim Cantin, Sylvie F. Gauthier, Yves Pouliot, Patrice E. Poubelle y Christina Juneau. "XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasisThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products." Canadian Journal of Physiology and Pharmacology 85, n.º 9 (septiembre de 2007): 943–51. http://dx.doi.org/10.1139/y07-084.
Texto completoTruckenbrodt, Hubert. "On the Relation between Syntactic Phrases and Phonological Phrases". Linguistic Inquiry 30, n.º 2 (abril de 1999): 219–55. http://dx.doi.org/10.1162/002438999554048.
Texto completoOnishi, Masazumi, Kanako Tsunoda, Fumihiko Maeda, Shinichi Moriwaki y Hiroo Amano. "Angiosarcoma of the Auricle in a Patient with Xeroderma Pigmentosum Variant". Case Reports in Dermatology 12, n.º 2 (18 de agosto de 2020): 144–49. http://dx.doi.org/10.1159/000508884.
Texto completoLueck, H., G. V. Minckwitz, A. Du Bois, I. Schrader, J. Huober, V. Heilmann, M. Beckmann et al. "Epirubicin/paclitaxel (EP) vs. capecitabine/paclitaxel (XP) in first-line metastatic breast cancer (MBC): A prospective, randomized multicentre phase III study of the AGO breast cancer study group". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 517. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.517.
Texto completo